| Name | Marc's |
|---|---|
| Organization Name | Marc Glassman Inc |
| Location | 7511 W Ridgewood Dr, Parma, Ohio 44129 |
| Type | Pharmacy |
| Phone | (440) 843-5495 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
Takeda Pharmaceutical Company Limited has announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.
Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his second annual letter - a personal appraisal of the foundation's efforts to date and how innovation impacts priorities of the foundation.
Kaiser Permanente, committed to improving the health of its patients, workforce and communities, announced today that it will require suppliers to provide environmental data for $1 billion worth of medical equipment and products used in its hospitals, medical offices and other facilities.
› Verified 7 days ago
| NPI Number | 1821003765 |
| Organization Name | MARC GLASSMAN INC |
| Doing Business As | MARCS |
| Type | Pharmacy |
| Address | 7511 W Ridgewood Dr, Parma, OH 44129 |
| Phone Number | 440-843-5495 |
News Archive
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
Takeda Pharmaceutical Company Limited has announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.
Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his second annual letter - a personal appraisal of the foundation's efforts to date and how innovation impacts priorities of the foundation.
Kaiser Permanente, committed to improving the health of its patients, workforce and communities, announced today that it will require suppliers to provide environmental data for $1 billion worth of medical equipment and products used in its hospitals, medical offices and other facilities.
› Verified 7 days ago
News Archive
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
Takeda Pharmaceutical Company Limited has announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.
Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his second annual letter - a personal appraisal of the foundation's efforts to date and how innovation impacts priorities of the foundation.
Kaiser Permanente, committed to improving the health of its patients, workforce and communities, announced today that it will require suppliers to provide environmental data for $1 billion worth of medical equipment and products used in its hospitals, medical offices and other facilities.
› Verified 7 days ago
Giant Eagle Pharmacy #6388 Type: Community/Retail Pharmacy Location: 7400 Broadview Rd, Parma, Ohio 44134 Phone: (216) 328-8263 | |
Health Aid Of Ohio Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5230 Hauserman Rd, Parma, Ohio 44130 Phone: (216) 252-3900 | |
Cvs Pharmacy #03817 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7412 State Rd, Parma, Ohio 44134 Phone: (440) 887-8038 | |
Rite Aid Pharmacy 03053 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5795 State Rd, Parma, Ohio 44134 Phone: (440) 884-3549 | |
Cvs Pharmacy #16245 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6850 Ridge Rd, Parma, Ohio 44129 Phone: (440) 842-9170 |